Abivax SA (ABVX) Earnings Date & Reports

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ABVX is expected to report earnings to fall 64.29% to -60 cents per share on December 14

Q3'26

Est.

$-0.60

Q2'26

Missed

by $1.08

Q1'26

Missed

by $0.10

Q4'25

Missed

by $0.54

Q3'25

Missed

by $1.79

The last earnings report on September 21 showed earnings per share of -167 cents, missing the estimate of -60 cents. With 155.95K shares outstanding, the current market capitalization sits at 8.33B.

View a ticker or compare two or three

ABVX

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for ABVX